NO942832L - Fremgangsmåte for utvinning av meget ren virus-inaktivert Faktor VIII ved anionbytter-kromatografi - Google Patents

Fremgangsmåte for utvinning av meget ren virus-inaktivert Faktor VIII ved anionbytter-kromatografi

Info

Publication number
NO942832L
NO942832L NO942832A NO942832A NO942832L NO 942832 L NO942832 L NO 942832L NO 942832 A NO942832 A NO 942832A NO 942832 A NO942832 A NO 942832A NO 942832 L NO942832 L NO 942832L
Authority
NO
Norway
Prior art keywords
pct
recovery
factor viii
anion exchange
exchange chromatography
Prior art date
Application number
NO942832A
Other languages
English (en)
Other versions
NO315426B1 (no
NO942832D0 (no
Inventor
Monika Stadler
Horst Schwinn
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6451895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO942832(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO942832L publication Critical patent/NO942832L/no
Publication of NO942832D0 publication Critical patent/NO942832D0/no
Publication of NO315426B1 publication Critical patent/NO315426B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
NO19942832A 1992-02-01 1994-07-29 Fremgangsmåte for utvinning av meget ren virus-inaktivert Faktor VIII/von Willebrand faktor kompleks ved anionbytterkromatografi NO315426B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4204694A DE4204694C3 (de) 1992-02-01 1992-02-01 Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
PCT/EP1993/000114 WO1993015105A1 (en) 1992-02-01 1993-01-20 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography

Publications (3)

Publication Number Publication Date
NO942832L true NO942832L (no) 1994-07-29
NO942832D0 NO942832D0 (no) 1994-07-29
NO315426B1 NO315426B1 (no) 2003-09-01

Family

ID=6451895

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19942832A NO315426B1 (no) 1992-02-01 1994-07-29 Fremgangsmåte for utvinning av meget ren virus-inaktivert Faktor VIII/von Willebrand faktor kompleks ved anionbytterkromatografi

Country Status (16)

Country Link
US (1) US5714590A (no)
EP (1) EP0625161B9 (no)
JP (1) JP3556947B2 (no)
KR (1) KR100240310B1 (no)
AT (1) ATE203249T1 (no)
AU (1) AU670776B2 (no)
DE (2) DE4204694C3 (no)
DK (1) DK0625161T4 (no)
ES (1) ES2157920T5 (no)
FI (1) FI109908B (no)
GR (1) GR3036849T3 (no)
NO (1) NO315426B1 (no)
PT (1) PT625161E (no)
RU (1) RU2096414C1 (no)
TW (1) TW362099B (no)
WO (1) WO1993015105A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005067A1 (en) * 1991-09-05 1993-03-18 Baxter International, Inc. Topical fibrinogen complex
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
MX2012005527A (es) * 2009-11-13 2012-08-08 Grifols Therapeutics Inc Preparaciones que contienen el factor de von willebrand (fvw) procedimientos, kits y aplicaciones relacionados con las mismas.
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
EP2652491B1 (en) 2010-12-15 2017-11-29 Baxalta GmbH Eluate collection using conductivity gradient
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3811042A1 (de) * 1988-03-31 1989-10-19 Merck Patent Gmbh Ionenaustauscher
ES2053619T3 (es) * 1988-05-27 1994-08-01 Centre Regional De Transfusion Procedimiento para la fabricacion de un factor antihemofilico de gran pureza y libre de virus mediante cromatografia.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Also Published As

Publication number Publication date
AU670776B2 (en) 1996-08-01
JPH07503241A (ja) 1995-04-06
WO1993015105A1 (en) 1993-08-05
EP0625161B9 (en) 2007-09-19
DE69330458T3 (de) 2008-01-17
KR100240310B1 (ko) 2000-01-15
EP0625161B2 (en) 2007-05-16
ATE203249T1 (de) 2001-08-15
DE4204694A1 (de) 1993-08-12
EP0625161B1 (en) 2001-07-18
FI943545A (fi) 1994-07-28
US5714590A (en) 1998-02-03
DE69330458T2 (de) 2002-05-29
RU2096414C1 (ru) 1997-11-20
AU3351793A (en) 1993-09-01
ES2157920T3 (es) 2001-09-01
DE69330458D1 (de) 2001-08-23
NO315426B1 (no) 2003-09-01
FI109908B (fi) 2002-10-31
FI943545A0 (fi) 1994-07-28
DE4204694C2 (de) 1994-02-10
PT625161E (pt) 2001-10-31
KR950700925A (ko) 1995-02-20
TW362099B (en) 1999-06-21
DK0625161T4 (da) 2007-09-03
DE4204694C3 (de) 1995-10-12
JP3556947B2 (ja) 2004-08-25
DK0625161T3 (da) 2001-09-24
EP0625161A1 (en) 1994-11-23
GR3036849T3 (en) 2002-01-31
ES2157920T5 (es) 2007-12-16
NO942832D0 (no) 1994-07-29

Similar Documents

Publication Publication Date Title
NO942832L (no) Fremgangsmåte for utvinning av meget ren virus-inaktivert Faktor VIII ved anionbytter-kromatografi
FR2730240B1 (no)
ATE143815T1 (de) Polymerbeschichtung
DK326785A (da) Terapeutisk middel til paavisning og/eller behandling af tumorer og fremgangsmaade til fremstilling af et saadant middel
NO925035L (no) Nye polyamider og gjenstander fremstilt derav
HUT56092A (en) Process for producing 2-amino-pyrimidine-4-carboxamide derivatives and pharmaceutical compositions containing them
FR2708601A1 (fr) Procédé de cristallisation d'Iopamidol.
KR840009069A (ko) 향정신성 펩티드류의 제조 방법
MX9302408A (es) Proceso de alcoxilacion.
PT763047E (pt) Novo processo para a preparacao de nucleosidos
RU94035758A (ru) Способ выделения высокоочищенного фактора yiii
DZ2056A1 (fr) Procédé de purification par extraction d'un milieuliquide et utilisation d'un tel procédé.
AU679132B2 (en) New eburnane analogues, a process for the preparation thereof and pharmaceutical compositions containing them
ES2113471T3 (es) Procedimiento de descloracion de los clorometanos superiores.
AU5522794A (en) New angiopeptin cyclopeptide compounds, process for the preparation thereof, and pharmaceutical compositios containing them
WO1997019916A3 (en) Bisazo compounds, intermediates thereof, process for synthesizing the same and therapeutic agent for viral infection containing the same
DE59305911D1 (de) Verwendung von Benzotriazinen als PLA2-Inhibitoren und neue Benzotriazine
GB9217823D0 (en) Chemical process
GEP20002295B (en) Dialkyl Ethers Having Terminal Carboxy or Tetrazole Groups

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees